Randomized evaluation of 5-month Ticagrelor monotherapy after 1-month dual-antiplatelet therapy in patients with acute coronary syndrome treated with drug-coated balloons: REC-CAGEFREE II trial rationale and design

Randomized evaluation of 5-month Ticagrelor monotherapy after 1-month dual-antiplatelet therapy in patients with acute coronary syndrome treated with drug-coated balloons: REC-CAGEFREE II trial rationale and design

Abstract Background Patients treated with drug-coated balloons (DCB) have the theoretical advantage of adopting a low-intensity antiplatelet regimen due to the absence of struts and polymers. Nevertheless, the optimal antiplatelet strategy for patients undergoing DCB-only treatment remains a topic o...

Full description

Bibliographic Details
Main Authors: Chao Gao, Bin Zhu, Jianzheng Liu, Zhiwei Jiang, Tao Hu, Qiong Wang, Yi Liu, Ming Yuan, Fei Li, Ruining Zhang, Jielai Xia, Yoshinobu Onuma, Duolao Wang, Patrick Serruys, Ling Tao, on behalf of the REC-CAGEFREE II Study Group
Format: Article
Language:English
Published: BMC 2024-01-01
Series:BMC Cardiovascular Disorders
Subjects:
Drug-coated balloon
Dual antiplatelet therapy
Acute coronary syndrome
Online Access:https://doi.org/10.1186/s12872-024-03709-1

Internet

https://doi.org/10.1186/s12872-024-03709-1

Similar Items